Conquering Non-invasive Imaging for Pre-clinical Drug Development

More than ever, we need the best minds working the best tools conquering the biggest challenges. To that point, pre-clinical drug development workflow includes toxicity evaluation at iteratively higher biological levels: cellular, tissue, organ, and whole organism. The ability to model and image at each of these levels is a powerful tool for molecule evaluation and development. Read more.

Non-Invasive Optical Imaging for Viral Research & Vaccine Development

Viral pathogens are the most common cause of respiratory infections, including influenza virus, measles, mumps, and coronaviruses (causing MERS-2012 and COVID-19). Read how non-invasive optical imaging enables the most intricate host-pathogen interactions to be visualized and monitored in disease models that mimic what is seen in humans.

The Role of In Vivo Imaging in Drug Discovery & Development

Advances in non-invasive in vivo imaging techniques have raised the use of animal models in preclinical drug discovery and development to a new level, enabling quick and efficient drug efficacy screening.


The IVIS┬« SpectrumCT preclinical in vivo imaging system expands upon the versatility of the IVIS Spectrum by offering 2D and 3D imaging capabilities but includes integrated low-dose microCT ideal for longitudinal studies.


Gulf Scientific Corporation (GSC) is a leading provider of complete laboratory solutions in the fields of analytical, life and material sciences. Founded in 1990, GSC is headquartered in Dubai, United Arab Emirates, with regional offices and supply chain distribution centers across the Middle East.´╗┐